The VIVA Foundation

The VIVA Foundation VIVA Physicians is a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research.

The VIVA Foundation is a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education, research, advocacy, and collaboration. Since 2003, VIVA Physicians has held an annual multidisciplinary vascular education conference for physicians and healthcare professionals dedicated to treating patients with vascular diseases. Attendees learn the most current diagnostic techniques and leading edge treatment strategies utilizing innovative technologies and creative learning platforms. The world renowned faculty emphasizes unbiased and critically evaluated educational content that highlights multidisciplinary perspectives and collaboration.

🚨 Exclusive Preview WebinarGet an early look at late-breaking trials ahead of   &  !Investigators will share the backgro...
09/26/2025

🚨 Exclusive Preview Webinar
Get an early look at late-breaking trials ahead of & !

Investigators will share the background, design, and methods. Results debut first-on-podium at the meetings.

Featuring:
JURY-2 Study
LIFE-BTK Trial
PROMISE III Trial
STRIKE-PE Trial
ROADSTER 3 Study

October 6, 2025 | 8pm ET / 5pm PT

Register now: https://us06web.zoom.us/webinar/register/WN_xY1ZiWvSQkOc-lKmHa8M6g #/registration

  Highlights- In-depth Focus Tracks on CLTI, Aortic, Dialysis, & PharmacoRx- Hands-on Cadaver Lab- Live Case Demonstrati...
09/22/2025

Highlights

- In-depth Focus Tracks on CLTI, Aortic, Dialysis, & PharmacoRx
- Hands-on Cadaver Lab
- Live Case Demonstrations
- Vascular Care Team Symposium
- The InnoSphere: Cutting-edge advancements in clinical, regulatory, & tech innovation

View the complete agenda: https://viva-foundation.org/agenda
Register now: https://viva-foundation.org/register

Missed it live? We’ve got you covered:- Elegance 12-month results- SPORTS 24-month outcomes- Meta-analysis on femoropopl...
09/16/2025

Missed it live? We’ve got you covered:

- Elegance 12-month results
- SPORTS 24-month outcomes
- Meta-analysis on femoropopliteal stenting

Leading voices in the field break it all down - don’t miss these insights.

Watch now:

From 12-month Elegance Registry findings to 24-month SPORTS data, plus a fresh meta-analysis on femoropopliteal stenting. Top experts unpacked the results de...

The clock is ticking! Prime pricing for   &   ends at midnight PST! Secure your spot (and savings) before tuition increa...
09/11/2025

The clock is ticking! Prime pricing for & ends at midnight PST! Secure your spot (and savings) before tuition increases tomorrow.

Register here: https://viva-foundation.org/register

🚨 It’s official: 23 trials selected to take the stage at   +  The most anticipated data in vascular medicine will be unv...
09/10/2025

🚨 It’s official: 23 trials selected to take the stage at +

The most anticipated data in vascular medicine will be unveiled this fall in Las Vegas.

View the complete announcement: https://viva-foundation.org/news-article?id=209295

Don't miss it. Register now: viva-foundation.org/register

What can you expect at   +  ?- 350+ Presentations- 150+ Global Faculty- Game-changing data, next-gen innovation & comple...
09/05/2025

What can you expect at + ?

- 350+ Presentations
- 150+ Global Faculty
- Game-changing data, next-gen innovation & complex cases that will shape your vascular practice

View the agenda - https://viva-foundation.org/agenda

⏳ Don’t miss out on PRIME pricing!Register for   &   by September 10 to lock in discounted tuition.Join us in Las Vegas ...
09/04/2025

⏳ Don’t miss out on PRIME pricing!

Register for & by September 10 to lock in discounted tuition.

Join us in Las Vegas this fall → November 1–5, 2025

https://viva-foundation.org/register

Just 3 hours to go! Join leading voices in PAD as they unpack Elegance, SPORTS & a new fem-pop meta-analysis. Don’t miss...
09/03/2025

Just 3 hours to go! Join leading voices in PAD as they unpack Elegance, SPORTS & a new fem-pop meta-analysis. Don’t miss the live discussion tonight.

Happening tonight: the newest PAD trial results in one focused hour.
âś” 12-month Elegance
âś” 24-month SPORTS
âś” New femoropopliteal meta-analysis
Live expert discussion on data debuted at LINC & CX.

Register now: https://viva-foundation.org/webinar-registration

Happening tonight: the newest PAD trial results in one focused hour.âś” 12-month Eleganceâś” 24-month SPORTSâś” New femoropopl...
09/03/2025

Happening tonight: the newest PAD trial results in one focused hour.
âś” 12-month Elegance
âś” 24-month SPORTS
âś” New femoropopliteal meta-analysis
Live expert discussion on data debuted at LINC & CX.

Register now: https://viva-foundation.org/webinar-registration

Don't miss this expert discussion on PAD data from LINC & Charing Cross including a new meta-analysis and updates from t...
09/02/2025

Don't miss this expert discussion on PAD data from LINC & Charing Cross including a new meta-analysis and updates from the SPORTS and Elegance trials.

September 3 | 8pm ET / 5pm PT | Free registration
Supported by Boston Scientific

Register here: https://viva-foundation.org/webinar-registration

Secure your spot before the weekend! Join us Sept 3 as global leaders break down the latest drug elution results from LI...
08/29/2025

Secure your spot before the weekend! Join us Sept 3 as global leaders break down the latest drug elution results from LINC & CX and what they mean for your practice.

How could 12-month Elegance, 24-month SPORTS, and new meta-analysis findings impact your practice?
Learn more Sept 3 as global leaders break down the newest drug elution results from LINC & CX.

Live webinar | 8pm ET / 5pm PT | Free registration
Register: https://viva-foundation.org/webinar-registration

Address

400 S. Farrell Drive, Suite B120
Palm Springs, CA
92262

Alerts

Be the first to know and let us send you an email when The VIVA Foundation posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Share

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram